Edition:
United States

People: Gilead Sciences Inc (GILD.O)

GILD.O on Nasdaq

83.27USD
22 Sep 2017
Change (% chg)

$0.65 (+0.79%)
Prev Close
$82.62
Open
$82.47
Day's High
$83.37
Day's Low
$82.01
Volume
5,654,657
Avg. Vol
9,345,653
52-wk High
$86.27
52-wk Low
$63.76

Alton, Gregg 

Mr. Gregg H. Alton is Executive Vice President - Corporate and Medical Affairs of Gilead Sciences IncMr. Alton joined us in 1999, and served as General Counsel from 2000 to 2009, when he was appointed to his current position. In his current role, Mr. Alton is responsible for legal affairs, government affairs, medical affairs, public affairs and emerging market activities. Prior to joining Gilead, Mr. Alton was an attorney at the law firm of Cooley Godward, LLP, where he specialized in mergers and acquisitions, corporate partnerships and corporate finance transactions for healthcare and information technology companies. Mr. Alton is a member of the boards of the AIDS Institute, the Boys and Girls Clubs of Oakland and Celladon Corporation. He is also a member of the U.S. Government’s Industry Trade Advisory Committee on Intellectual Property Rights, the advisory boards of UCSF Global Health Sciences, USC Schaeffer Center for Health Policy and Economics, Pharmozyme, Inc. and the Dean’s Advisory Council at Stanford Law School. In addition, he serves on Partners In Health’s Board of Trustees. Mr. Alton received a bachelor’s degree in legal studies from the University of California at Berkeley, and holds a JD from Stanford University.

Basic Compensation

Total Annual Compensation, USD 925,385
Restricted Stock Awards, USD 1,695,600
Long-Term Incentive Plans, USD --
All Other, USD 2,704,590
Fiscal Year Total, USD 5,325,570

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 35,874 2,619,740.00
Name Fiscal Year Total

John Martin

10,442,400

John Milligan

13,935,200

Robin Washington

5,068,060

Kevin Young

5,639,670

Norbert Bischofberger

6,169,470

Gregg Alton

5,325,570
As Of  30 Dec 2016